Nancy C Reich Marshall

7PUBLICATIONS
4CO-AUTHORS
Molecular targetsCancer cell biologyChild and adolescent developmentHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 26, 2025
STAT3 sustains tumorigenicity following mutant KRAS ablation.

Stephen D'Amico, Varvara Kirillov, Jingxuan Liu

|Mar 10, 2025
STAT3 Sustains Tumorigenicity Following Mutant KRAS Ablation.

Stephen D'Amico, Varvara Kirillov, Jingxuan Liu

|Apr 04, 2024
STAT3 is a genetic modifier of TGF-beta induced EMT in KRAS mutant pancreatic cancer.

Stephen D'Amico, Varvara Kirillov, Oleksi Petrenko

|Oct 02, 2023
Oncogenic dependency plays a dominant role in the immune response to cancer.

Jinyu Li, Stephen D'Amico, Varvara Kirillov

|Feb 23, 2022
Howard Young Commentary.

Nancy C Reich Marshall

|Mar 06, 2021
KRAS drives immune evasion in a genetic model of pancreatic cancer.

Irene Ischenko, Stephen D'Amico, Manisha Rao

Pageof 2